57 related articles for article (PubMed ID: 18610735)
21. Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy.
Nishiyama M; Eguchi H
Adv Drug Deliv Rev; 2009 May; 61(5):402-7. PubMed ID: 19133303
[TBL] [Abstract][Full Text] [Related]
22. [New insights in the adjuvant treatment of gastric cancer].
Jansen EP; Boot H; Cats A; van Coevorden F; Zoetmulder FA; Verheij M
Ned Tijdschr Geneeskd; 2004 Dec; 148(51):2529-34. PubMed ID: 15636473
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
Bittoni A; Maccaroni E; Scartozzi M; Berardi R; Cascinu S
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):309-14. PubMed ID: 20496540
[TBL] [Abstract][Full Text] [Related]
24. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
[TBL] [Abstract][Full Text] [Related]
25. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
Liu TS; Wang Y; Chen SY; Sun YH
Eur J Surg Oncol; 2008 Nov; 34(11):1208-16. PubMed ID: 18353606
[TBL] [Abstract][Full Text] [Related]
26. Disparities in gastric cancer chemotherapy between the East and West.
Ohtsu A; Yoshida S; Saijo N
J Clin Oncol; 2006 May; 24(14):2188-96. PubMed ID: 16682738
[TBL] [Abstract][Full Text] [Related]
27. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
Wagner AD; Moehler M
Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
[TBL] [Abstract][Full Text] [Related]
28. Gastric cancer.
Catalano V; Labianca R; Beretta GD; Gatta G; de Braud F; Van Cutsem E
Crit Rev Oncol Hematol; 2009 Aug; 71(2):127-64. PubMed ID: 19230702
[TBL] [Abstract][Full Text] [Related]
29. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
Ozols RF
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.
Sun P; Xiang JB; Chen ZY
Br J Surg; 2009 Jan; 96(1):26-33. PubMed ID: 19016271
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of gastric cancer].
Lordick F; Ridwelski K; Al-Batran SE; Trarbach T; Schlag PM; Piso P
Onkologie; 2008; 31 Suppl 5():32-9. PubMed ID: 19033703
[TBL] [Abstract][Full Text] [Related]
32. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
33. Systemic treatment of gastric cancer.
Morabito A; Carillio G; Longo R
Crit Rev Oncol Hematol; 2009 Jun; 70(3):216-34. PubMed ID: 18829344
[TBL] [Abstract][Full Text] [Related]
34. [Adjuvant chemotherapy in gastric carcinoma].
Degiuli M; Ortega C; Mineccia M
Ann Ital Chir; 2001; 72(1):55-8. PubMed ID: 11464497
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy for metastatic gastric cancer in Japan.
Boku N
Int J Clin Oncol; 2008 Dec; 13(6):483-7. PubMed ID: 19093174
[TBL] [Abstract][Full Text] [Related]
36. Recent developments in chemotherapy of advanced gastric cancer.
Götze T; Schütte K; Röcken C; Malfertheiner P; Ebert MP
Dig Dis; 2004; 22(4):360-5. PubMed ID: 15812160
[TBL] [Abstract][Full Text] [Related]
37. Brief review of advances in the treatment of gastric carcinoma in North America and Europe, 1995-2001.
Hasham-Jiwa N; Kasakura Y; Ajani JA
Int J Clin Oncol; 2002 Aug; 7(4):219-24. PubMed ID: 12202975
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant therapy for gastric carcinoma: closing out the century.
Yao JC; Shimada K; Ajani JA
Oncology (Williston Park); 1999 Nov; 13(11):1485-94; discussion 1497-502 passim. PubMed ID: 10581599
[TBL] [Abstract][Full Text] [Related]
39. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
40. Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience.
Shibata M; Nezu T; Fujisaki S; Andou K; Tomita R; Fukuzawa M
Dig Surg; 2002; 19(4):255-60. PubMed ID: 12207066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
